Sample size determination for group sequential clinical trials with immediate response
- 1 January 1992
- journal article
- research article
- Published by Wiley in Statistics in Medicine
- Vol. 11 (10) , 1391-1399
- https://doi.org/10.1002/sim.4780111012
Abstract
The use function approach to group sequential methods has been explored previously. Any group sequential design requires specifying the frequency and times of repeated analyses, but only the use function approach allows deviations from those specified in the design, without affecting the type I error in the analysis. This paper illustrates how the use function provides a simple and flexible design procedure and how the initially projected maximum sample size can be calculated for randomized clinical trials in which responses are known relatively soon after patient entry and for which there is an early stopping rule built into the study protocol. Also the consequence of using the proposed design procedure is investigated in terms of the operating characteristics of the subsequent group sequential analyses.Keywords
This publication has 13 references indexed in Scilit:
- Effects of Tamoxifen on Bone Mineral Density in Postmenopausal Women with Breast CancerNew England Journal of Medicine, 1992
- Design and analysis of group sequential tests based on the type I error spending rate functionBiometrika, 1987
- The Thrombolysis in Myocardial Infarction (TIMI) TrialNew England Journal of Medicine, 1985
- Discrete Sequential Boundaries for Clinical TrialsBiometrika, 1983
- Group sequential methods in the design and analysis of clinical trialsBiometrika, 1977
- Repeated Significance Tests on Accumulating Data when the Null Hypothesis is not TrueJournal of the Royal Statistical Society. Series A (General), 1971
- Repeated Significance Tests on Accumulating DataJournal of the Royal Statistical Society. Series A (General), 1969